The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.93% advanced 1.08% to $59.13 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.82% rising 0.22% to 14,746.40 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.21% falling 0.15% to 33,919.84. This was the ADR's second consecutive day of gains. AstraZeneca PLC ADR closed $1.80 short of its 52-week high ($60.93), which the company reached on July 12th.
The ADR demonstrated a mixed performance when compared to some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.35% rose 0.70% to $107.15, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.12% rose 0.12% to $215.36, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.37% rose 1.09% to $71.73. Trading volume (8.6 M) remained 2.5 million below its 50-day average volume of 11.1 M.